Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Biomarkers: FDA Working To Define 'Reasonably Likely To Predict' Standard

07 Sep 2015

• By Derrick Gingery

Related Content

Biomarker Development Meeting May Help Expand Accelerated Approval

21 Jul 2014

PDUFA V: Final Recommendations Fund Proposals In Two Of Three Tiers

02 May 2011

‘Precision Medicine’ Gets R&D Funding Push In President’s Speech

21 Jan 2015

PDUFA Budgeting: What Will Get Added, Subtracted – Or Multiplied By Cures?

02 Sep 2015

Biomarkers In Orphan Studies Still Need Past Experience, FDA Says

27 May 2013

Additional Topics

United States Clinical Trials Drug Approval Standards BioPharmaceutical Medical Device

More from United States

More from North America

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.